Diabetic Neuropathic Pain Treatment Landscape 2024: Comprehensive Insights About 10+ Companies and 12+ Pipeline Drugs - Product Type, Stage, Route of Administration, and Molecule Type
01 juil. 2024 07h38 HE
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Neuropathic Pain - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Diabetic Neuropathic...
Major Neuropathic Pain Markets, Epidemiology, Trends, and Analysis to 2034: A Projected $8.1 Billion Opportunity
28 juin 2024 10h12 HE
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Neuropathic Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
Global Peripheral Neuropathy Market Report 2022: Strategic Insight and Analysis of Key Drivers, Market Factors & Players
25 oct. 2022 06h33 HE
|
Research and Markets
Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
US Neuropathic Pain Market and Competitive Landscape Report 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecasts, Drugs Sales
31 mai 2021 08h08 HE
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "US Neuropathic Pain Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Neuropathic Pain Market and...